Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.
Press releases published on April 2, 2025
TISSIUM Announces Clinical Results of COAPTIUM® CONNECT System for Atraumatic Sutureless Nerve Repair
GlobeNewswire
·
April 2, 2025
Paris, France, Cambridge, USA, April 2nd, 2025 - TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, is proud to unveil clinical data which were presented at the IFSSH Congress in Washington, D. …
Early Warning News Release
GlobeNewswire
·
April 2, 2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 02, 2025 (GLOBE NEWSWIRE) -- This news release is being issued by Dr. Sven Grail ("Dr. Grail") and Grail Family Foundation (the “Foundation”) as required …
TeamHealth and Array Behavioral Care partner to transform emergency behavioral health treatment
GlobeNewswire
·
April 2, 2025
KNOXVILLE, Tenn., April 02, 2025 (GLOBE NEWSWIRE) -- TeamHealth, a physician-founded and led practice of 18,000 clinicians and operational team members partnering with more than 2,400 hospitals and facilities, today announced a strategic partnership with …
Clinical Asset Management leader TRIMEDX selects Neil de Crescenzo as new CEO
GlobeNewswire
·
April 2, 2025
Indianapolis, Indiana, April 02, 2025 (GLOBE NEWSWIRE) -- TRIMEDX—a leading independent clinical asset management company specializing in comprehensive clinical engineering services, clinical asset informatics, and medical device cybersecurity—has …
Crisis Text Line Launches Dedicated Hotline to Support Americans Facing Financial Stress
GlobeNewswire
·
April 2, 2025
New York, April 02, 2025 (GLOBE NEWSWIRE) -- Rising economic uncertainty is placing a heavy burden on both financial and mental well-being. With concerns about layoffs, tariffs, a possible recession, and personal financial instability on the rise, many …
Sienna Announces First Quarter 2025 Results Release Date and Conference Call
GlobeNewswire
·
April 2, 2025
MARKHAM, Ontario, April 02, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2025 first quarter results after market close on Tuesday, May 6, 2025. Nitin Jain, President and Chief …
AscellaHealth Releases Q1 2025 Specialty & Rare Pipeline Digest™ Providing Essential Clinical Drug Updates
GlobeNewswire
·
April 2, 2025
BERWYN, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today unveiled its latest Specialty …
Sienna Senior Living Completes Previously Announced Acquisitions in Alberta and British Columbia
GlobeNewswire
·
April 2, 2025
MARKHAM, Ontario, April 02, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced today that it has finalized its previously announced acquisition of a portfolio of four continuing care homes in Alberta (" …
Polyrizon Engages Leading Branding Firm for Strategic Brand Development
GlobeNewswire
·
April 2, 2025
Raanana, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ), a biotech company specializing in innovative intranasal hydrogels, today announced that it has entered into an agreement with a globally recognized branding and trademark …
Hint Health Announces Hint Summit 2025 at RosettaFest, Uniting DPC with the Future of Healthcare
GlobeNewswire
·
April 2, 2025
SAN FRANCISCO, Calif, April 02, 2025 (GLOBE NEWSWIRE) -- Hint Summit is back—and more connected than ever! This year, Hint Health is taking its flagship event to the next level, bringing Hint Summit 2025 to RosettaFest August 24-27 at the Colorado …
Prime Biome Reviews DON’T SKIP UNTIL SEE THIS for Preventing Fraud and Guaranteeing Reliability!
GlobeNewswire
·
April 2, 2025
ST. PETERSBURG, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- 2025, a popular supplement for reviving the gut and skin micro biota, Prime Biome has swept the wellness industry. Prime Biome is the greatest option for safe, healthy skin out of all the products …
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend the 24th Annual Needham …
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
GlobeNewswire
·
April 2, 2025
HOUSTON, TX, April 02, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that it has successfully enrolled the …
FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair
GlobeNewswire
·
April 2, 2025
HOUSTON, April 02, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases …
Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025
GlobeNewswire
·
April 2, 2025
Event exploring the escalating threat of emerging infectious diseases Discussion covering going-private transaction with Aditxt, strategic growth partner HALIFAX, Nova Scotia, April 02, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: …
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
GlobeNewswire
·
April 2, 2025
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today reported …
Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program
GlobeNewswire
·
April 2, 2025
Rolling submission of BLA initiated for tividenofusp alfa; preparations ongoing for potential U.S. commercial launch in late 2025 or early 2026 Alignment through recent interactions with CDER on path to accelerated approval and conversion to full approval …
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, today announced that …
MUHC Foundation celebrates $200M Dream Big campaign milestone
GlobeNewswire
·
April 2, 2025
MONTREAL, April 02, 2025 (GLOBE NEWSWIRE) -- The McGill University Health Centre (MUHC) Foundation is proud to announce the successful completion of its ambitious Dream Big campaign, which has surpassed its $200 million fundraising goal. Launched in 2020 …
La campagne Oser rêver de la Fondation du CUSM franchit son objectif de 200 millions de dollars
GlobeNewswire
·
April 2, 2025
MONTRÉAL, 02 avr. 2025 (GLOBE NEWSWIRE) -- La Fondation du Centre universitaire de santé McGill (CUSM) est fière d’annoncer que son ambitieuse campagne Oser rêver a dépassé son objectif de financement de 200 millions de dollars. Lancée en 2020 durant une …